Client of a consultant lobbyist
Breast Cancer Canada
- Meetings this Parliament
- 11
- With MPs
- 3
- Since Nov 2021
- 15
- Active registrations
- 1
Most recent reported meeting: Oct 6, 2026.
Lobbying by Breast Cancer Canada: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingWho they meet
Since the current Parliament opened.
MPs
- Maggie Chi Liberal 2
- Laila Goodridge Conservative 2
- Lisa Hepfner Liberal 1
- Raquel Dancho Conservative 1
- Marcus Powlowski Liberal 1
- Helena Jaczek Liberal 1
Institutions
- Health Canada (HC)8
- House of Commons3
- Women and Gender Equality (WAGE)1
- Senate of Canada1
Registrations in effect
Consultant In effect since Jun 12, 2026
Consultant Danielle Flieler of Santis Health
Consultant lobbyists
- Danielle Flieler
- Danielle Flieler
- Danielle Flieler
- Danielle Flieler
- Danielle Flieler
Institutions they may lobby: Canadian Institutes of Health Research (CIHR), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Public Health Agency of Canada (PHAC), Senate of Canada, Women and Gender Equality (WAGE)
What they're lobbying on (3)Hide details
- Discussions on the restructuring of the Canadian Preventative Health Task Force
- Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
- Communicating with government to increase investments in health research
Registration 953997-377486-7. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by Danielle Flieler · Consultant
- Maggie Chi · Member of Parliament
- Helena Jaczek · Member of Parliament
- Raquel Dancho · Member of Parliament
- Lisa Hepfner · Member of Parliament
and 2 moreShow fewer
- Jibril Hussein · Intern, Health Canada (HC)
- Justine Frame · Policy Advisor, Health Canada (HC)
Communicating with government to increase investments in health research Read more
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
-
Reported by Danielle Flieler · Consultant
- Michael Collins · VP of Health Promotion at PHAC, Health Canada (HC)
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
-
Reported by Danielle Flieler · Consultant
- Jibril Hussein · Intern, Health Canada (HC)
Discussions on the restructuring of the Canadian Preventative Health Task Force
-
Reported by Danielle Flieler · Consultant
- Jibril Hussein · Intern, Health Canada (HC)
Discussions on the restructuring of the Canadian Preventative Health Task Force Read more
Communicating with government to increase investments in health research
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
-
Reported by Danielle Flieler · Consultant
- Danièle Henkel · Senator, Senate of Canada
Communicating with government to increase investments in health research Read more
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
-
Reported by Danielle Flieler · Consultant
- Justine Frame · Special Assistant, Policy, Health Canada (HC)
- Jibril Hussein · Intern, Health Canada (HC)
Discussions on the restructuring of the Canadian Preventative Health Task Force Read more
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
-
Reported by Danielle Flieler · Consultant
- Carina Gabriele · Director of Policy, Women and Gender Equality (WAGE)
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
-
Reported by Danielle Flieler · Consultant
- Maggie Chi · Parliamentary Secretary, Health Canada (HC)
- Laila Goodridge · Member of Parliament
- Marcus Powlowski · Member of Parliament
- Justine Frame · Special Assistant, Policy, Health Canada (HC)
Discussions on the restructuring of the Canadian Preventative Health Task Force Read more
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
-
Reported by Danielle Flieler · Consultant
- Laila Goodridge · Member of Parliament
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
-
Reported by Danielle Flieler · Consultant
- Michael Collins · VP of Health Promotion at PHAC, Health Canada (HC)
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
-
Reported by Danielle Flieler · Consultant
- Roy Karam · Senior Policy Advisor, Health Canada (HC)
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
-
Reported by Danielle Flieler · Consultant
- Mark Holland · Minister of Health, Health Canada (HC)
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
-
Reported by Danielle Flieler · Consultant
- Mark Holland · Minister of Health, Health Canada (HC)
Health
-
Reported by Danielle Flieler · Consultant
- Laila Goodridge · MP
Health
-
Reported by Danielle Flieler · Consultant
- Anna Roberts · MP
- Lisa Hepfner · Member of Parliament
- Len Webber · MP, House of Commons
- Leah Taylor Roy · MP, House of Commons
Health
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.